Henrike Bruckmueller

No ORCID on file · 1 paper in corpus
lab-animal 2025
BMC cancer ·doi:10.1186/s12885-025-14434-z

BACKGROUND: Aberrant changes in protein phosphorylation are a hallmark of cancer, often leading to hyperactivation of signalling pathways such as the mitogen activated protein kinase (MAPK) pathway. Although kinase inhibitors are successful…